Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.64M | -11.64M | 3.82M | 3.82M | -15.82M |
| Total Depreciation and Amortization | 92.00K | 92.00K | 238.00K | 238.00K | 106.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.53M | 2.53M | 896.00K | 896.00K | 1.53M |
| Change in Net Operating Assets | 1.20M | 1.20M | -8.95M | -8.95M | 5.88M |
| Cash from Operations | -7.82M | -7.82M | -3.99M | -3.99M | -8.29M |
| Capital Expenditure | -157.00K | -157.00K | -218.00K | -218.00K | 104.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.71M | -7.71M | 6.36M | 6.36M | 20.34M |
| Cash from Investing | -7.86M | -7.86M | 6.14M | 6.14M | 20.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 74.00K | 74.00K | -74.00K | -74.00K | 72.00K |
| Issuance of Common Stock | 62.50K | 62.50K | 51.00K | 51.00K | 11.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 136.50K | 136.50K | -23.00K | -23.00K | 83.50K |
| Foreign Exchange rate Adjustments | -252.50K | -252.50K | -45.00K | -45.00K | -178.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.80M | -15.80M | 2.08M | 2.08M | 12.06M |